Background/Objective: Previous cohort studies examining the association of serum antioxidant levels and risk of colorectal cancer have used a single (baseline) measurement only. In the present study, we assessed the association of serum levels of eight antioxidant nutrients in relation to risk of colorectal cancer, using repeated measurements. Subjects/Methods: Data on a subsample of women in the Women's Health Initiative with repeated measurements of serum retinol, a-carotene, b-carotene, b-cryptoxanthin, lutein þ zeaxanthin, lycopene, a-tocopherol and g-tocopherol during follow-up were included in the analysis. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CIs). Results: Among 5477 women with baseline serum antioxidant values, 88 incident cases of colorectal cancer were identified over a median follow-up time of 12 years. Serum antioxidants measured at baseline generally showed no association with risk of colorectal cancer, although serum b-carotene at baseline showed a non-significant inverse association with colon cancer alone. Furthermore, using the repeated measurements of b-carotene, the average of all measurements was inversely associated with risk of both colorectal and colon cancer: HRs for highest vs lowest tertile 0.54, 95% CI 0.31-0.96, and 0.47, 95% CI 0.25-0.88, respectively. No associations were seen with other antioxidant nutrients in the repeated measure analyses. Conclusions: In this study, baseline levels of antioxidant nutrients were not associated with risk of colorectal or colon cancer; however, using repeated measures, a relatively high serum level of b-carotene (average of all measurements) was inversely associated with risk of colon and colorectal cancer in postmenopausal women.
Introduction
Over the past 30 years, there has been strong interest in the possibility that a high intake of fruits and vegetables-and the resulting high circulating levels of antioxidant nutrients-might protect against the development of cancer (Peto et al., 1981) . There is now convincing experimental evidence that antioxidant compounds found in fruits and vegetables can inhibit the carcinogenic process through a variety of mechanisms (de Kok et al., 2010) and may offer protection against colorectal carcinogenesis (Shivapurkar et al., 1995; Briviba et al., 2001; Raju et al., 2005; Tang et al., 2008) . However, epidemiologic studies that have examined intake of fruits and vegetables in relation to risk of colorectal cancer have not shown clear or consistent evidence of an association (Key, 2011) . A major review of the epidemiologic evidence concluded that there is 'limited/suggestive evidence' that a high intake of fruits and non-starchy vegetables is associated with decreased risk of colorectal cancer (AICR, 2007) .
A number of prospective studies have examined blood levels of specific antioxidant nutrients in relation to colorectal cancer risk, with conflicting results (Stähelin et al., 1984; Nomura et al., 1985; Schober et al., 1987; Wald et al., 1987 Wald et al., , 1988 Knekt, 1988; Knekt et al., 1990; Comstock et al., 1992; Longnecker et al., 1992; Malila et al., 2002; Ito et al., 2005; Wakai et al., 2005) . Some of these studies had small numbers of cases (Stähelin et al., 1984; Wald et al., 1987 Wald et al., , 1988 Knekt, 1988; Knekt et al., 1990; Ito et al., 2005) ; one study examined mortality as an outcome , whereas most examined incidence; and one study reported strong but conflicting results in men and women (Wakai et al., 2005) . Only three of the previous studies examined non-provitamin A carotenoids as well as provitamin A carotenoids (Malila et al., 2002; Ito et al., 2005; Wakai et al., 2005) .
Characterizing an individual's habitual, predisease nutritional status over a long period of time is difficult, and a single measurement may not be adequate for this purpose (Rohan, 2001 ). To our knowledge, no study has included repeated measurements of serum carotenoid, retinol and tocopherol levels, which might provide a better measure of exposure over time. We, therefore, undertook an analysis of fasting antioxidant nutrient levels in relation to colorectal cancer risk, using the subsample of subjects in the Women's Health Initiative (WHI) who had repeated measurements of these nutrients during follow-up.
Materials and methods

Study population
The WHI is a large, prospective, multi-center study of factors affecting the health of postmenopausal women. It includes an observational study (OS) (N ¼ 93 676) and clinical trials (CT) (N ¼ 68 132) of hormone therapy, dietary modification and calcium plus vitamin D supplementation (The Women's Health Initiative Study Group, 1998) . Women were recruited at 40 clinical centers throughout the United States, largely via direct mailings, and were eligible to participate if they were postmenopausal, aged 50-79, likely to reside in their current residence for at least 3 years, and provided written informed consent. The CT had a number of additional eligibility requirements (Chlebowski et al., 2005) . In general, eligible women were first invited to enroll in the CT component. Women who did not wish to be randomly assigned to an intervention or who were ineligible for the CT component were then invited to participate in the OS. Other women entered the OS due to recruitment for that component. Enrollment took place between 1 October 1993 and 31 December 1998.
The present analysis is based on the 6% random sample of women in the CT (N ¼ 4544) who provided fasting blood samples at baseline and at years 1, 3 and 6 of follow-up and a 1% sample of women in the OS (N ¼ 1062) who provided fasting blood samples at baseline and at year 3. The 6% random sample was stratified by age, clinical center and hysterectomy status, with over-sampling of minority groups to increase the numbers of Black, Hispanic and Asian-Pacific women. All protocols and procedures were approved by Institutional Review Boards at participating institutions. Of the 5606 women with blood samples, the 5477 who had baseline measurements of the eight antioxidant nutrients (1061 from the OS and 4416 from the CT) were used in the present analysis.
Of the 5477 women with baseline antioxidant measurements, the numbers with measurements during follow-up were: 3921 (71.6%-year 1), 3445 (62.9%-year 3), and 3188 (58.2%-year 6). The proportions were similar for different blood draws among cases and non-cases.
Case ascertainment
In the CT, cancer outcomes were ascertained through semiannual, self-administered questionnaires, and then confirmed by centralized review of pathology reports, discharge summaries, operative and radiology reports, and tumor registry abstracts by trained medical adjudicators. After the end of trial period (2005), outcomes were identified from annual mailed questionnaires. In the OS, ascertainment of outcomes was performed on an annual basis throughout the study period, with confirmation as for the CT cases.
Laboratory methods
Blood samples were collected after an overnight fast (12 h) with minimal stasis and maintained at 4 1C until plasma or serum was separated. Plasma or serum aliquots were then frozen at À70 1C and sent on dry ice to the WHI central repository (Fisher BioServices, Rockville, MD, USA) for storage at À70 1C. Retinol, a-carotene, b-carotene, b-cryptoxanthin, lycopene, lutein þ zeaxanthin, a-tocopherol and g-tocopherol were measured in serum by reverse-phase highperformance liquid chromatography (Miller et al., 1984; Kaplan et al., 1990) . After the addition of an internal standard, serum was extracted into hexane and injected onto a C18 reverse-phase column. The analytes were measured at wavelengths of 292 and 452 nm. CVs were determined in pooled blood samples from four age-eligible female volunteers. The CVs for the eight analytes ranged from 6.0 (a-tocopherol) to 20.4 (a-carotene).
Statistical analysis
Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CIs) for the associations of serum antioxidant nutrients with risk of colorectal cancer, with duration of follow-up (days) as the time scale. For these analyses, study participants were considered to be at risk from their date of enrollment until the date of diagnosis of their colorectal cancer, termination of follow-up (30 September 2010), loss of follow-up, withdrawal from the study, or death, whichever occurred first. Event times of participants who had not developed colorectal cancer by the end of follow-up, who had died, or who had withdrawn from the study before the end of follow-up, were censored.
Baseline analysis
In the first stage of the analysis, we estimated the risk of colorectal cancer in association with baseline serum antioxidant nutrients. Tertiles of the eight study variables were created based on their distribution in the total study population. Age-adjusted and multivariable-adjusted HR were computed. Variables were selected for inclusion in the multivariable analysis if their addition to the model changed the parameter estimate of the study factors by 410% or if they were significantly associated with risk. Variables included in the final model were: age (continuous), body mass index (kg/m 2 -continuous), waist circumference (cmcontinuous), age at first live birth (o20, 20-29, X30 years, missing), alcohol intake (drinks per week-continuous), physical activity (MET-hrs/week-continuous), family history of colorectal cancer (no, yes), ethnicity (white, black, other), enrollment in OS vs CT. Given that intervention status may have affected the post baseline measurement of serum antioxidants and may also have influenced the risk of colorectal cancer, we included dummy variables for treatment arm of each of the CT in all models. Additional models included serum cholesterol, serum triglycerides, dietary fat intake, dietary folate intake, energy intake and use of vitamin/mineral supplements. Tests for trend were performed by assigning the median value to each category and modeling this variable as a continuous variable. In order to examine the possibility that preclinical disease might have influenced serum nutrient levels, we conducted a sensitivity analysis, excluding cases that were diagnosed during the first year of follow-up.
Analysis of repeated measures
In the second stage of the analysis, the repeated measurements of the eight antioxidant nutrients were analyzed by modeling them as time-dependent covariates in Cox proportional hazards models (Gail, 1981) . With this approach, we evaluated the predictive value of the most recent measurement, measurements obtained 1-3 years, 2-4 years and 3-5 years before the date of diagnosis of colorectal cancer, and the mean of all available measurements. Among cases, measurements that were obtained within 1 year of diagnosis were excluded from all analyses, as these values may have been influenced by the presence of sub-clinical disease. The time-dependent analyses were not adjusted for multiple testing because the results were used primarily to confirm trends observed with the baseline data. All P-values were two-sided.
Results
During a median follow-up period of 11.9 years, a total of 88 colorectal cancer cases were ascertained in the cohort of 5477 women with serum antioxidant nutrient values at baseline. In all, 72 cases had colon cancer, 5 had cancer of the rectosigmoid junction and 11 had rectal cancer. Among cases, 11 were in the OS and 77 were in the CT; a total of 50 cases were not in any intervention group. Among non-cases, 1050 were in the OS and 4339 were in the CT; a total of 3202 non-cases were not in any intervention group.
Compared with non-cases, on average cases were older, were more likely to have a family history of colorectal cancer in a first-degree relative, and to be non-Hispanic white (for distribution of baseline characteristics of cases and noncases, see Table 1 ). Cases and non-cases were broadly similar with respect to other factors. Mean baseline blood levels of antioxidants did not differ between the two groups.
In the baseline analysis, none of the eight antioxidant nutrients was associated with risk of colorectal cancer (Table 2) . However, serum b-carotene showed a borderline significant inverse association with risk of colon cancer: multivariable-adjusted HRs for intermediate and highest tertiles vs lowest tertile were 0.52, 95% CI 0.29-0.94 and 0.61, 95% CI 0.33-1.10, respectively, P for trend 0.09. None of the other nutrients showed any association with colorectal or colon cancer risk. Age-adjusted and multivariableadjusted analyses gave similar results. Additional models including serum cholesterol, serum triglycerides, dietary fat intake, dietary folate intake, energy intake, use of vitamin/ mineral supplements, and participation in the OS or specific treatment arm of each of the CT did not materially affect the results. When cases diagnosed during the first year of followup (N ¼ 6) were excluded, serum b-carotene was no longer associated with colon cancer: HRs for the second and third tertiles were 0.59 (95% CI 0.32-1.10) and 0.76 (95% CI 0.41-1.41), respectively, P for trend 0.36. In time-dependent covariate analysis for b-carotene, tertiles of the average of all measurements were inversely associated with colorectal cancer and colon cancer: HRs (95% CI) for second and third tertiles were 0.65 (0.39-1.09) and 0.54 (0.31-0.96), P for trend 0.03 and 0.57 (0.32-1.00) and 0.47 (0.25-0.88), P for trend 0.01, respectively (Table 3) . For colon cancer, the model including b-carotene measurements 1-3 years before diagnosis showed the strongest association, but the other time lag windows also suggested reductions in risk at the highest tertile level (Table 3) . Similar patterns, albeit not statistically significant, were observed for colorectal cancer. None of the other nutrients was significantly associated with risk in the time-dependent covariates analysis (data not shown).
Discussion
Baseline levels of the eight antioxidant nutrients were not significantly associated with risk of colorectal cancer, and baseline b-carotene showed a weak, borderline inverse association with risk of colon cancer. However, in timedependent covariates analysis, the average of all b-carotene measurements was inversely associated with risk of both colorectal and colon cancer.
Mechanisms by which antioxidant nutrients may inhibit colorectal carcinogenesis include scavenging of reactive intermediates (de Kok et al., 2010) ; inhibition of cell proliferation (Tang et al., 2008; de Kok et al., 2010) ; inhibition of formation or progression of aberrant crypt foci (Shivapurkar et al., 1995; Raju et al., 2005) ; induction of cell differentiation (de Kok et al., 2010) ; and induction of apoptosis (Briviba et al., 2001; de Kok et al., 2010) .
Previous prospective studies which have examined the association of serum or plasma carotenoids, retinol and tocopherols with risk of colorectal cancer have generally shown null results (Stähelin et al., 1984; Nomura et al., 1985; Schober et al., 1987; Wald et al., 1987 Wald et al., , 1988 Knekt, 1988; Knekt et al., 1990; Comstock et al., 1992; Longnecker et al., 1992; Malila et al., 2002; Ito et al., 2005; Wakai et al., 2005) . Most studies had small numbers of cases; used a one-time measurement of each nutrient; were not able to adjust for a number of risk factors for colorectal cancer; and did not examine the possibility of reverse causation. Furthermore, few examined specific forms of carotenoids or tocopherols.
A number of early studies examined serum levels of b-carotene, vitamin A, retinol, and/or vitamin E with risk of colon or colorectal cancer (Stähelin et al., 1984; Nomura et al., 1985; Schober et al., 1987; Wald et al., 1987 Wald et al., , 1988 Knekt, 1988; Knekt et al., 1990) , with generally null results. The number of cases in these studies ranged from 15 (Stähelin et al., 1984) to 81 (Nomura et al., 1985) . A pooled analysis of the association of the early studies of serum a-tocopherol with subsequent risk of colorectal cancer in five prospective studies (N cases ¼ 289) (Longnecker et al., 1992) obtained an odds ratio of 0.6 (95% CI 0.4-1.0) for the highest vs the lowest quartile. However, adjustment for serum cholesterol levels attenuated the odds ratio to 0.7 (95% CI 0.4-1.1).
Only three of the previous studies examined non-provitamin A carotenoids as well as provitamin A carotenoids (Malila et al., 2002; Ito et al., 2005; Wakai et al., 2005 ). An analysis of data from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (N cases ¼ 184) (Malila et al., 2002) found no significant association of serum a-tocopherol, b-carotene or retinol with risk of colorectal cancer. In a small study in rural Japan, with 21 deaths from colorectal cancer , a high serum level of total carotenoids was associated with reduced mortality from colorectal cancer, and a-carotene, b-carotene and lycopene showed borderline significant inverse associations with risk. Serum b-cryptoxanthin, zeaxanthin & lutein, retinol and a-tocopherol were not associated with altered risk. In a larger study from Japan, Wakai et al. (2005) measured micronutrients in prediagnostic serum samples from 116 men and women in the Japan Collaborative Cohort Study who developed colorectal cancer during 8 years of follow-up and from 298 matched controls. In men (N ¼ 54), higher levels of serum total carotenoids were associated with decreased risk (multivariable-adjusted OR for highest vs lowest tertile 0.34, 95% CI 0.11-1.00, P for trend 0.04). In women (N ¼ 62), higher levels of a-and b-carotene and total carotenoids were associated with increased risk (multivariable-adjusted ORs for the highest vs lowest tertile were 4.72, 95% CI 1.29-17.3, P for trend 0.007; 2.00, 95% CI 0.70-5.73, P for trend ¼ 0.04; and 2.47, 95% CI 0.73-8.34, P for trend 0.06, respectively).
To our knowledge, no previous study has included repeated measurements of serum carotenoid, retinol and tocopherol levels. Baseline b-carotene levels were not associated with colorectal cancer, and a weak borderline inverse association was seen with colon cancer. Using the repeated measurement data, we observed that the average of all b-carotene measurements was inversely associated with both colorectal and colon cancer risk. When different time lags preceding diagnosis were considered, the measurement 1-3 years prior showed the strongest association. This apparent strengthening of the association could be due to the improvement characterizing an individual's habitual levels owing to use of multiple measurements and to the specific timing of measurements in relation to diagnosis. We observed a similar finding in a study of breast cancer (Kabat et al., 2009) . The finding of a stronger inverse association with more recent measurements may reflect a late-stage effect. This would be consistent with evidence that carotenoids may have a role in the inhibition of cell proliferation (Sharoni et al., 2003) , rather than in the inhibition of cancer initiation. However, it is also possible that the inverse association of b-carotene observed in the repeated measure analysis is a chance finding, given the large number of comparisons. Larger cohorts with serial measurements are needed to confirm our results.
Our study had a number of strengths. We were able to adjust for a number of potential confounding variables, including serum total cholesterol, triglycerides and insulin, and total fat intake and energy intake. In addition, we conducted a sensitivity analysis to account for possible effects of early subclinical disease on serum levels of antioxidant nutrients. Finally, we used repeated measurement data to obtain a more reliable estimate of each individual's serum levels than that provided by a single measurement and, which may be more relevant to antioxidant defenses against cancer.
The principal limitation of our study is the small number of cases, and particularly for analyses of subgroups, such as women who were not in any CT intervention arm, subsites within the colorectum, and various windows considered in the time-dependent covariates analysis.
In conclusion, with the exception of an inverse association of serum b-carotene level with risk of colon cancer and possibly with colorectal cancer, the present study found no associations of antioxidant nutrients with risk of colorectal or colon cancer. Our results underscore the need for larger studies with repeated measurements of blood antioxidant levels in order to assess their possible protective role in colorectal cancer.
